JaLCDOI | 10.18926/AMO/32184 |
---|---|
FullText URL | fulltext.pdf |
Author | Hirasawa, Ryoto| Hashimoto, Hozo| Makino, Shinya| Suemaru, Shuso| Takao, Toshihiro| Ota, Zensuke| Hoshida, Yoshihiko| Yoshino, Tadashi| Akagi, Tadaatsu| |
Abstract | A 46-year-old woman with acromegaly and hyperthyroidism due to a pituitary adenoma. She had high serum thyroid-stimulating hormone (TSH) levels and very high serum growth hormone (GH) levels. Transsphenoidal removal of the tumor, post-operative irradiation, frontal craniotomy for removal of residual tumor and large-dose bromocriptine therapy were carried out consecutively. After therapy, serum GH levels gradually decreased, but not to the normal range, and serum TSH levels remained at inappropriately normal levels. Using immunoperoxidase techniques, GH-, TSH- and follicle-stimulating hormone (FSH)-containing cells were demonstrated in the adenoma. A long-acting somatostatin analogue (SMS 201-995, 600 micrograms/day) suppressed the serum GH level to the normal range with a concomitant suppression of TSH. Furthermore, the paradoxical serum GH responses to TRH and LH-RH were slightly improved. No important subjective side-effects were noted. Therefore, SMS 201-995 appeared to be a very effective drug in this patient with a GH- and TSH-producing pituitary tumor.</P> |
Keywords | TSH- and GH - producing pituitary adenoma acromegaly heperthyroidism somatostatin analogue (SMS 201-995) |
Amo Type | Article |
Publication Title | Acta Medica Okayama |
Published Date | 1991-04 |
Volume | volume45 |
Issue | issue2 |
Publisher | Okayama University Medical School |
Start Page | 107 |
End Page | 115 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 1867112 |
Web of Science KeyUT | A1991FL60800007 |
JaLCDOI | 10.18926/AMO/32209 |
---|---|
FullText URL | fulltext.pdf |
Author | Mukuzono, Hiroshi| Yoshino, Tadashi| Akagi, Tadaatsu| |
Abstract | A monoclonal antibody (MAb), OPT1, reactive with T cells in formalin-fixed, paraffin-embedded tissue sections, has been identified through immunization with activated T cells from peripheral blood lymphocytes (PBL). The antibody is an IgG1 antibody as demonstrated by the Ouchterlony technique. By cytofluorometric analysis, almost all CD3+ lymphocytes and only a few CD20+ lymphocytes of peripheral blood expressed the OPT1 antigen. Nonhematolymphoid cell lines were negative for OPT1 by the immunoperoxidase staining using acetone-fixed cell lines. On the contrary, peripheral T cells, cells of two T cell lines out of four and a part of the cells of one B cell line out of two were positive for OPT1. The immunoperoxidase staining of paraffin-embedded tissue sections revealed that most of lymphocytes in T cell areas of lymph nodes expressed OPT1 antigen. Some lymphocytes in both cortex and medulla of the thymus and erythroid precursors of the bone marrow were OPT1+. In the malignant lymphoma series, approximately 90% of T cell lymphomas and 6% of B cell lymphomas reacted with OPT1. None of the Reed-Sternberg cells nor Hodgkin cells in Hodgkin's disease were positive. Consequently, OPT1 may be useful for the diagnosis and study of malignant lymphomas and other related lesions.</P> |
Keywords | monoclonal antibody OPTI T cells lymphocytes lymphoma |
Amo Type | Article |
Publication Title | Acta Medica Okayama |
Published Date | 1991-06 |
Volume | volume45 |
Issue | issue3 |
Publisher | Okayama University Medical School |
Start Page | 147 |
End Page | 154 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 1891974 |
Web of Science KeyUT | A1991FV15000004 |
JaLCDOI | 10.18926/AMO/32293 |
---|---|
FullText URL | fulltext.pdf |
Author | Jin, Zaishun| Teramoto, Norihiro| Yoshino, Tadashi| Takada, Kenzo| Oka, Takashi| Hayashi, Kazuhiko| Akagi, Tadaatsu| |
Abstract | It has been reported that Epstein-Barr virus (EBV) resides in resting B cells in vivo. However, an ideal in vitro system for studying EBV latent infection in vivo has not yet been established. In this study, a mantle cell lymphoma line, SP53, was successfully infected with a recombinant EBV containing a neomycin-resistant gene. The EBV-carrying SP53 cells were obtained by selection using G418. They expressed EBER-1, EBNAs, and LMP1; this expression pattern of the EBV genes was similar to that in a lymphoblastoid cell line (LCL). However, proliferation assay showed that the EBV-carrying SP53 cells have a doubling time of 73 h, compared with 57 h of SP53 cells. Transplantation of 10(8) SP53 cells to nude mice formed tumors in 4 of 10 mice inoculated, but the EBV-carrying SP53 cells did not. Unexpectedly, EBV infection reduced the proliferation and tumorigenicity of SP53 cells. However, the EBV-carrying SP53 cells showed higher resistance to apoptosis induced by serum starvation than did the SP53 cells. The inhibition of proliferation and the resistance to apoptosis induced in SP53 cells by EBV infection indicate that this cell line might to some extent provide a model of in vivo EBV reservoir cells. |
Keywords | Epstein-Barr virus mantle cell lymphoma latent infection in vivo reservoir SP53 line |
Amo Type | Article |
Publication Title | Acta Medica Okayama |
Published Date | 2000-10 |
Volume | volume54 |
Issue | issue5 |
Publisher | Okayama University Medical School |
Start Page | 193 |
End Page | 200 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 11061568 |
Web of Science KeyUT | 000090098600002 |
JaLCDOI | 10.18926/AMO/32620 |
---|---|
FullText URL | fulltext.pdf |
Author | Takata, Hiroshi| Yoshino, Tadashi| Hoshida, Yoshihiko| Takata, Ikuko| Akagi, Tadaatsu| |
Abstract | A cell line of human lung large cell carcinoma (LCC) was established directly from the metastatic skin tumor tissue. The clinical course of the patient who carried this carcinoma was peculiar; generalized lymphadenopathy, histologically resembling Hodgkin's disease, was found as the first clinical symptom. The lung tumor was not discovered until the time of autopsy. This cell line (KaMi) grew adherent to culture vessels with the population doubling time of 20.6h, formed colonies in soft agars with efficiency of 22.6%, and formed tumors in athymic nude mice. The authenticity of KaMi was confirmed by chromosomal analysis and isoenzyme patterns. KaMi cells bore a strong resemblance to the original tumor cells which were composed of small spindle cells, large polygonal cells, and multinucleated giant cells. Immunohistochemically, KaMi cells showed a weak tendency to differentiate to squamous cells, and these immunohistochemical reactivities were almost compatible to those of the original tumor cells, but ultrastructurally, KaMi cells were more immature than the original ones. Treatment with several reagents could not augment a differentiation of KaMi cells. Cytokeratin profiles showed a tendency of squamous cell differentiation. KaMi cells may aid in elucidating the pathogenesis and biology of LCC and its relationship to other lung tumors. |
Keywords | Large cell lung carcinoma cell line cytokeratin |
Amo Type | Article |
Publication Title | Acta Medica Okayama |
Published Date | 1992-08 |
Volume | volume46 |
Issue | issue4 |
Publisher | Okayama University Medical School |
Start Page | 257 |
End Page | 264 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 1279943 |
Web of Science KeyUT | A1992JL44200005 |
JaLCDOI | 10.18926/AMO/32636 |
---|---|
FullText URL | fulltext.pdf |
Author | Kondo, Eisaku| Yoshino, Tadashi| Akagi, Tadaatsu| Hayashi, Kazuhiko| Takahashi, Kiyoshi| |
Abstract | Southern blot hybridization was used to detect the rearrangement and amplification of five proto-oncogenes (bcl-2, bcl-1, c-myc, c-myb and c-Ha-ras) and one tumor suppressor gene (RB-1) in 55 Japanese patients with non-Hodgkin's lymphoma; 16 with T-cell lymphomas and 39 with B-cell lymphomas (7 follicular and 32 diffuse lymphomas). Genetic abnormalities of the proto-oncogenes were detected in 7 of the 55 (13%). Genetic abnormalities of bcl-2 plus other genes were detected in 5 of 7 cases of follicular lymphoma (71%), rearrangements of bcl-2 and c-myc, rearrangement of bcl-2 and amplification of c-myb. Genetic abnormalities were observed in only three cases of diffuse lymphoma. In each of 3 cases of B-cell lymphoma, one of the genes, blc-2 mbr, bcl-2 mcr and c-myc, was rearranged respectively. The incidence of genetic abnormalities in diffuse lymphomas (6.3%) was lower than that in follicular lymphomas. None of diffuse lymphomas had double oncogene abnormality. No abnormalities were found in RB-1, bcl-1, and Ha-ras. These findings suggest that follicular lymphomas are associated with some abnormalities of oncogenes not restricted to bcl-2 that facilitate growth which may be associated with their clinical features. |
Keywords | malignant lymphoma cellular oncogenes |
Amo Type | Article |
Publication Title | Acta Medica Okayama |
Published Date | 1992-12 |
Volume | volume46 |
Issue | issue6 |
Publisher | Okayama University Medical School |
Start Page | 407 |
End Page | 415 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 1485535 |
Web of Science KeyUT | A1992KE49600002 |
JaLCDOI | 10.18926/AMO/51072 |
---|---|
FullText URL | 67_4_265.pdf |
Author | Hanakawa, Hiroyuki| Orita, Yorihisa| Sato, Yasuharu| Uno, Kinya| Nishizaki, Kazunori| Yoshino, Tadashi| |
Abstract | We present a case of a 67-year-old Japanese man with a serious oropharyngeal ulceration that at first seemed to be destructive malignant lymphoma or oropharyngeal carcinoma. We suspected methotrexate (MTX)-associated lymphoproliferative disorder (LPD) induced by MTX treatment for rheumatoid arthritis (RA). About 3 weeks after simple discontinuation of MTX, complete regression of the disease was observed, confirming our diagnosis. |
Keywords | ulceration methotrexate oropharynx lymphoproliferative disorders |
Amo Type | Case Report |
Publication Title | Acta Medica Okayama |
Published Date | 2013-08 |
Volume | volume67 |
Issue | issue4 |
Publisher | Okayama University Medical School |
Start Page | 265 |
End Page | 269 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
Copyright Holders | CopyrightⒸ 2013 by Okayama University Medical School |
File Version | publisher |
Refereed | True |
PubMed ID | 23970326 |
Web of Science KeyUT | 000323470100009 |
JaLCDOI | 10.18926/AMO/53120 |
---|---|
FullText URL | 69_1_37.pdf |
Author | Iwamuro, Masaya| Okada, Hiroyuki| Takata, Katsuyoshi| Kawai, Yoshinari| Kawano, Seiji| Nasu, Junichiro| Kawahara, Yoshiro| Tanaka, Takehiro| Yoshino, Tadashi| Yamamoto, Kazuhide| |
Abstract | The sensitivity and specificity of magnified endoscopic features for differentiating follicular lymphoma from other diseases with duodenal whitish lesions have never been investigated. Here we compared the magnified endoscopic features of duodenal follicular lymphoma with those of other whitish lesions. We retrospectively reviewed the cases of patients with follicular lymphoma (n=9), lymphangiectasia (n=7), adenoma (n=10), duodenitis (n=4), erosion (n=1), lymphangioma (n=1), and hyperplastic polyp (n=1). The magnified features of the nine follicular lymphomas included enlarged villi (n=8), dilated microvessels (n=5), and opaque white spots of various sizes (n=9). The lymphangiectasias showed enlarged villi, dilated microvessels, and white spots, but the sizes of the white spots were relatively homogeneous and their margin was clear. Observation of the adenoma and duodenitis revealed only whitish villi. Although the lymphangioma was indistinguishable from the follicular lymphomas by magnified features, it was easily diagnosed based on the macroscopic morphology. In conclusion, magnified endoscopic features, in combination with macroscopic features, are useful for differentiating follicular lymphomas from other duodenal diseases presenting whitish lesions. |
Keywords | duodenal neoplasm follicular lymphoma gastrointestinal lymphoma magnifying endoscopy |
Amo Type | Original Article |
Publication Title | Acta Medica Okayama |
Published Date | 2015-02 |
Volume | volume69 |
Issue | issue1 |
Publisher | Okayama University Medical School |
Start Page | 37 |
End Page | 44 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
Copyright Holders | CopyrightⒸ 2015 by Okayama University Medical School |
File Version | publisher |
Refereed | True |
PubMed ID | 25703169 |
Web of Science KeyUT | 000349740300004 |
JaLCDOI | 10.18926/AMO/53676 |
---|---|
FullText URL | 69_5_301.pdf |
Author | Seki, Anna| Iwamuro, Masaya| Yoshioka, Masao| Fujii, Nobuharu| Okada, Hiroyuki| Nose, Soichiro| Takata, Katsuyoshi| Yoshino, Tadashi| Yamamoto, Kazuhide| |
Abstract | A 41-year-old woman was diagnosed with duodenal follicular lymphoma. She had no other lesions and was assigned to a "watch and wait" policy. Swelling of the inguinal lymph nodes appeared 45 months later, and rituximab monotherapy resulted in complete remission. However, follicular lymphoma recurred in the stomach, rectum and mesenteric and external iliac lymph nodes 81 months after the therapy. The patient received rituximab monotherapy again and has remained in complete remission in the fifteenth year after the initial diagnosis. This case suggests the usefulness of rituximab monotherapy in the long-term management of intestinal follicular lymphoma. |
Keywords | follicular lymphoma duodenum rituximab |
Amo Type | Case Report |
Publication Title | Acta Medica Okayama |
Published Date | 2015-10 |
Volume | volume69 |
Issue | issue5 |
Publisher | Okayama University Medical School |
Start Page | 301 |
End Page | 306 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
Copyright Holders | CopyrightⒸ 2015 by Okayama University Medical School |
File Version | publisher |
Refereed | True |
PubMed ID | 26490027 |
Web of Science KeyUT | 000365519600006 |
JaLCDOI | 10.18926/AMO/54815 |
---|---|
FullText URL | 70_6_503.pdf |
Author | Kanazawa, Yui| Yamashita, Yuka| Fujiwara, Mitsuhiro| Muraoka, Michiko| Washio, Kana| Kanamitsu, Kiichiro| Ishida, Hisashi| Nakano, Takae| Yamada, Miho| Horibe, Keizo| Tanaka, Takehiro| Yoshino, Tadashi| Shimada, Akira| |
Abstract | Childhood anaplastic large cell lymphoma (ALCL) accounts for approx. 10–30 of cases of non-Hodgkin lymphoma, and the ALCL99 study reported 60–75 disease-free survival; however, a relatively high relapse rate was observed (25–30 ). We report 2 patients with Stage III ALCL who relapsed 6–18 months after the end of ALCL99 chemotherapy. A retrospective molecular analysis identified the nucleophosmin (NPM)-anaplastic lymphoma kinase (ALK) fusion gene in the first diagnostic bone marrow samples taken from both patients. However, antibodies against the ALK protein appeared to be relatively low in the serum of both patients (×100 and ×750). An increase in chemotherapy intensity may be beneficial if Stage III ALCL patients are shown to be NPM-ALK chimera-positive in the first diagnostic bone marrow sample. |
Keywords | ALCL NPM-ALK fusion lymphoma |
Amo Type | Case Report |
Publication Title | Acta Medica Okayama |
Published Date | 2016-12 |
Volume | volume70 |
Issue | issue6 |
Publisher | Okayama University Medical School |
Start Page | 503 |
End Page | 506 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
Copyright Holders | CopyrightⒸ 2016 by Okayama University Medical School |
File Version | publisher |
Refereed | True |
PubMed ID | 28003677 |
JaLCDOI | 10.18926/AMO/54978 |
---|---|
FullText URL | 71_2_105.pdf |
Author | Shinya, Takayoshi| Tanaka, Takashi| Soh, Junichi| Matsushita, Toshi| Sato, Shuhei| Toyooka, Shinichi| Yoshino, Tadashi| Miyoshi, Shinichiro| Kanazawa, Susumu| |
Abstract | We retrospectively assessed the dual-time-point (DTP) F-18 FDG PET/CT findings of thymic epithelial neoplasms (TENs) and investigated the diagnostic capacity of PET/CT compared to that of CT for predicting carcinoma. We calculated the ratio of the standardized uptake value of the tumor and that of the aortic arch (T/M ratio) for both the 90-min early scan and the 2-h delayed scan in 56 TEN patients. We used a multivariate logistic regression (MLR) analysis to estimate the CT features of carcinoma. We compared the diagnostic capacities of PET/CT and chest CT using receiver operating characteristic (ROC) analyses. The ROC curve revealed that the appropriate cut-off T/M ratio value for the highest accuracy was 2.39 with 75.0% accuracy. The area under the curve (AUC) was 0.855. The statistical analyses for DTP scans of 35 TEN patients demonstrated 74.3% accuracy and 0.838 AUC for the early scan versus 82.9% and 0.825 for the delayed scan. The MLR analysis indicated that mediastinal fat infiltration was a predictor of carcinoma. The ROC curve obtained for the model yielded an AUC of 0.853. Delayed scanning could improve the diagnostic capacity for carcinoma. The T/M ratio and mediastinal fat infiltration are predictive of carcinoma with moderate diagnostic accuracy. |
Keywords | thymic epithelial neoplasm thymic carcinoma thymoma dual-time-point PET/CT chest CT |
Amo Type | Original Article |
Publication Title | Acta Medica Okayama |
Published Date | 2017-04 |
Volume | volume71 |
Issue | issue2 |
Publisher | Okayama University Medical School |
Start Page | 105 |
End Page | 112 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
Copyright Holders | CopyrightⒸ 2017 by Okayama University Medical School |
File Version | publisher |
Refereed | True |
PubMed ID | 28420891 |
JaLCDOI | 10.18926/AMO/64363 |
---|---|
FullText URL | 77_1_65.pdf |
Author | Sato, Ken| Takigawa, Nagio| Kubo, Toshio| Katayama, Hideki| Kishino, Daizo| Okada, Toshiaki| Hisamoto, Akiko| Mimoto, Junko| Ochi, Nobuaki| Yoshino, Tadashi| Ueoka, Hiroshi| Tanimoto, Mitsune| Maeda, Yoshionobu| Kiura, Katsuyuki| |
Abstract | We investigated the effects of celecoxib combined with (−)-epigallocatechin-3-gallate (EGCG) or polyphenon E in a cisplatin-induced lung tumorigenesis model. Four-week-old female A/J mice were divided into seven groups: (i) Control, (ii) 150 mg/kg celecoxib (150Cel), (iii) 1,500 mg/kg celecoxib (1500Cel), (iv) EGCG+150 mg/kg celecoxib (EGCG+150Cel), (v) EGCG+1,500 mg/kg celecoxib (EGCG+1500Cel), (vi) polyphenon E+150 mg/kg celecoxib (PolyE+150Cel), and (vii) polyphenon E+1,500 mg/kg celecoxib (PolyE+1500Cel). All mice were administered cisplatin (1.62 mg/kg of body weight, i.p.) 1×/week for 10 weeks and sacrificed at week 30; the numbers of tumors on the lung surface were then determined. The tumor incidence and multiplicity (no. of tumors/mouse, mean±SD) were respectively 95% and 2.15±1.50 in Control, 95% and 2.10±1.29 in 150Cel, 86% and 1.67±1.20 in 1500Cel, 71% and 1.38±1.24 in EGCG+150Cel, 67% and 1.29±1.38 in EGCG+1500Cel, 80% and 1.95±1.36 in PolyE+150Cel, and 65% and 1.05±0.10 in PolyE+1500Cel. The combination of high-dose celecoxib with EGCG or polyphenon E significantly reduced multiplicity in cisplatin-induced lung tumors. |
Keywords | celecoxib cisplatin EGCG lung tumor polyphenon E |
Amo Type | Original Article |
Publication Title | Acta Medica Okayama |
Published Date | 2023-02 |
Volume | volume77 |
Issue | issue1 |
Publisher | Okayama University Medical School |
Start Page | 65 |
End Page | 70 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
Copyright Holders | Copyright Ⓒ 2023 by Okayama University Medical School |
File Version | publisher |
Refereed | True |
PubMed ID | 36849147 |
Web of Science KeyUT | 000952992100004 |
Author | Nakagawa, Kazuhiko| Noguchi, Yuji| Okumura, Hideo| Sato, Shuichiro| Tanaka, Motoyuki| Shimono, Michihide| Ali Eldib, Ali Mohamed| Aoe, Motoi| Ono, Toshiro| Uenaka, Akiko| Ohara, Nobuya| Yoshino, Tadashi| Yamashita, Kazuki| Tsunoda, Tsukasa| Shimizu, Nobuyoshi| Nakayama, Eiichi| |
---|---|
Published Date | 2007-09-03 |
Publication Title | 岡山医学会雑誌 |
Volume | volume119 |
Issue | issue2 |
Content Type | Journal Article |
Author | Takata, Katsuyoshi| Yoshino, Tadashi| |
---|---|
Published Date | 2008-01-04 |
Publication Title | 岡山医学会雑誌 |
Volume | volume119 |
Issue | issue3 |
Content Type | Journal Article |
Author | 吉野 正| 赤木 忠厚| |
---|---|
Published Date | 2001-04-28 |
Publication Title | 岡山医学会雑誌 |
Volume | volume113 |
Issue | issue1 |
Content Type | Journal Article |
Author | Liu, Keyue| Mori, Shuji| Takahashi, Hideo| Tomono, Yasuko| Wake, Hidenori| Kanke, Toru| Sato, Yasuharu| Hiraga, Norihito| Adachi, Naoto| Yoshino, Tadashi| Nishibori, Masahiro| |
---|---|
Published Date | 2008-12-01 |
Publication Title | 岡山医学会雑誌 |
Volume | volume120 |
Issue | issue3 |
Content Type | Journal Article |
Author | Sato, Yasuharu| Yoshino, Tadashi| |
---|---|
Published Date | 2010-04-01 |
Publication Title | 岡山医学会雑誌 |
Volume | volume122 |
Issue | issue1 |
Content Type | Journal Article |
Author | Okuma, Yu| Liu, Keyue| Wake, Hidenori| Haruma, Jun| Yoshino, Tadashi| Ohtsuka, Aiji| Takahashi, Hideo| Mori, Shuji| Nishibori, Masahiro| Date, Isao| |
---|---|
Published Date | 2013-08-01 |
Publication Title | 岡山医学会雑誌 |
Volume | volume125 |
Issue | issue2 |
Content Type | Journal Article |
Author | Takata, Katsuyoshi| Sato, Yasuharu| Nakamura, Naoya| Tokunaka, Mami| Miki, Yukari| Kikuti, Yara Yukie| Igarashi, Kazuhiko| Ito, Etsuro| Harigae, Hideo| Kato, Seiichi| Hayashi, Eiko| Oka, Takashi| Hoshii, Yoshinobu| Tari, Akira| Okada, Hiroyuki| Mohamado, ABD Alkader Lamia| Maeda, Yoshinobu| Tanimoto, Mitsune| Kinoshita, Tomohiro| Yoshino, Tadashi| |
---|---|
Published Date | 2013-08-01 |
Publication Title | 岡山医学会雑誌 |
Volume | volume125 |
Issue | issue2 |
Content Type | Journal Article |
Author | Miki, Yukari| Gion, Yuka| Mukae, Yuriko| Hayashi, Atsushi| Sato, Hiaki| Yoshino, Tadashi| Takahashi, Kiyoshi| |
---|---|
Published Date | 2013-02 |
Publication Title | European Journal of Haematology |
Volume | volume90 |
Issue | issue2 |
Content Type | Journal Article |
Author | Toda, Hiroko| Sato, Yasuharu| Takata, Katsuyoshi| Orita, Yorihisa| Asano, Naoko| Yoshino, Tadashi| |
---|---|
Published Date | 2013-02-28 |
Publication Title | PLoS ONE |
Volume | volume8 |
Issue | issue2 |
Content Type | Journal Article |